BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7753891)

  • 1. Inhibition of lordosis in female hamsters and rats by 8-OH-DPAT treatment.
    Hebert TJ; Menard CS; Dohanich GP
    Physiol Behav; 1995 Mar; 57(3):523-7. PubMed ID: 7753891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior treatment with estrogen attenuates the effects of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
    Jackson A; Uphouse L
    Horm Behav; 1996 Jun; 30(2):145-52. PubMed ID: 8797023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced efficacy of 8-OH-DPAT's inhibition of lordosis behavior by prior estrogen treatment.
    Trevino A; Wolf A; Jackson A; Price T; Uphouse L
    Horm Behav; 1999 Jun; 35(3):215-23. PubMed ID: 10373334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen-progesterone and 8-OH-DPAT attenuate the lordosis-inhibiting effects of the 5-HT1A agonist in the VMN.
    Uphouse L; Caldarola-Pastuszka M; Maswood S; Andrade M; Moore N
    Brain Res; 1994 Feb; 637(1-2):173-80. PubMed ID: 8180795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior.
    Truitt W; Harrison L; Guptarak J; White S; Hiegel C; Uphouse L
    Brain Res; 2003 Jun; 974(1-2):202-11. PubMed ID: 12742638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of lordosis behavior by the putative 5-HT receptor agonist 8-OH-DPAT in the rat.
    Ahlenius S; Fernandez-Guasti A; Hjorth S; Larsson K
    Eur J Pharmacol; 1986 May; 124(3):361-3. PubMed ID: 2942412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent effects of estradiol benzoate on 5-HT1A receptor agonist action.
    Jackson A; Uphouse L
    Brain Res; 1998 Jun; 796(1-2):299-302. PubMed ID: 9689482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strain differences in the response to the 5-HT1A receptor agonist, 8-OH-DPAT.
    Uphouse L; Maswood S; Jackson A; Brown K; Prullage J; Myers T; Shaheen F
    Pharmacol Biochem Behav; 2002 Jun; 72(3):533-42. PubMed ID: 12175449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen modulates 5-HT(1A) agonist inhibition of lordosis behavior but not binding of [(3)H]-8-OH-DPAT.
    Jackson A; Etgen AM
    Pharmacol Biochem Behav; 2001 Feb; 68(2):221-7. PubMed ID: 11267626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of the serotonin1A agonist, 8-OH-DPAT, on masculine and feminine sexual behavior of the ferret.
    Paredes RG; Kica E; Baum MJ
    Psychopharmacology (Berl); 1994 May; 114(4):591-6. PubMed ID: 7855220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors elevating cAMP attenuate the effects of 8-OH-DPAT on lordosis behavior.
    Uphouse L; Maswood S; Jackson A
    Pharmacol Biochem Behav; 2000 Jun; 66(2):383-8. PubMed ID: 10880694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 5-HT1A-receptor agonist, 8-OH-DPAT, and GABAB-receptor agonist, baclofen, on lordosis in female rats with lesions in either the dorsal raphe nucleus or septum.
    Kishitake M; Yamanouchi K
    J Pharmacol Sci; 2005 Aug; 98(4):419-24. PubMed ID: 16079463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the 5-HT1A agonist, 8-OH-DPAT, on sexual behaviors of the proestrous rat.
    Uphouse L; Montanez S; Richards-Hill R; Caldarola-Pastuszka M; Droge M
    Pharmacol Biochem Behav; 1991 Jul; 39(3):635-40. PubMed ID: 1838412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuating effects of prior oestradiol benzoate priming on 5-HT-mediated lordosis behavior in rats are dose-dependent.
    Siddiqui A; Shaharyar S
    Acta Physiol Hung; 2007 Sep; 94(3):209-21. PubMed ID: 17853773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol modulation of the hyperphagia induced by the 5-HT1A agonist, 8-OH-DPAT.
    Salamanca S; Uphouse L
    Pharmacol Biochem Behav; 1992 Nov; 43(3):953-5. PubMed ID: 1448492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABAA-5-HT1A receptor interaction in the mediobasal hypothalamus.
    Guptarak J; Selvamani A; Uphouse L
    Brain Res; 2004 Nov; 1027(1-2):144-50. PubMed ID: 15494165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WAY100635 and female rat lordosis behavior.
    Uphouse L; Wolf A
    Brain Res; 2004 Jul; 1013(2):260-3. PubMed ID: 15193537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PKC inhibitor, bisindolymaleimide, blocks DOI's attenuation of the effects of 8-OH-DPAT on female rat lordosis behavior.
    Selvamani A; Lincoln C; Uphouse L
    Behav Brain Res; 2007 Apr; 179(1):99-106. PubMed ID: 17336403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of estrogen treatment on scopolamine inhibition of lordosis.
    Menard CS; Hebert TJ; Ross SM; Dohanich GP
    Horm Behav; 1992 Sep; 26(3):364-74. PubMed ID: 1398555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen reduces serotonin-1A receptor-mediated oxytocin release and Galpha(i/o/z) proteins in the hypothalamus of ovariectomized rats.
    D'Souza DN; Zhang Y; Damjanoska KJ; Carrasco GA; Sullivan NR; Garcia F; Battaglia G; Doncarlos LL; Muma NA; Van de Kar LD
    Neuroendocrinology; 2004; 80(1):31-41. PubMed ID: 15385710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.